J Gojo, M Kjaersgaard, B Zezschwitz, D Capper… - European Journal of …, 2023 - Elsevier
The introduction of molecular methods into the diagnostics of central nervous system (CNS) tumours and the subsequent deciphering of their molecular heterogeneity has resulted in a …
Background Only few data are available on treatment-associated behavior of distinct rare CNS embryonal tumor entities previously treated as “CNS-primitive neuroectodermal …
S Khan, P Solano-Paez, T Suwal, M Lu… - The Lancet Child & …, 2021 - thelancet.com
Background Embryonal tumours with multi-layered rosettes (ETMRs) are a newly recognised, rare paediatric brain tumour with alterations of the C19MC microRNA locus …
The 5th edition of the WHO Classification of Tumours of the Central Nervous System introduces new entities, and provides updated guidance regarding the diagnostic criteria for …
MM Blessing, S Alexandrescu - Surgical Pathology Clinics, 2020 - surgpath.theclinics.com
Embryonal tumors of the central nervous system (CNS) are rare, high-grade neoplasms predominantly affecting the pediatric population. Well-defined embryonal tumors include …
BO Juhnke, M Gessi, NU Gerber, C Friedrich… - Neuro …, 2022 - academic.oup.com
Background Embryonal tumors with multilayered rosettes (ETMR) are highly aggressive tumors occurring in early childhood. Published clinical data refer to retrospective …
DM Meredith, DJ Pisapia - CONTINUUM: Lifelong Learning in …, 2023 - journals.lww.com
Objective The classification of brain tumors is a rapidly evolving field that requires extensive integration of molecular diagnostic findings from an expanding set of platforms and assays …
K Bailey, N Pandit-Taskar, JL Humm… - Journal of Neuro …, 2019 - Springer
Purpose We explored the use of intraventricular 131 I-Omburtamab targeting B7-H3 in patients with ETMR. Methods Patients were enrolled in an IRB approved, phase 1, 3+ 3 …